Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(21%)
Results Posted
25%(2 trials)

Phase Distribution

Ph phase_2
3
21%
Ph phase_3
1
7%
Ph phase_4
2
14%
Ph phase_1
1
7%
Ph not_applicable
6
43%

Phase Distribution

1

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
2(15.4%)
N/ANon-phased studies
6(46.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(8)
Other(3)

Detailed Status

Completed8
unknown3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 23 (23.1%)
Phase 31 (7.7%)
Phase 42 (15.4%)
N/A6 (46.2%)

Trials by Status

active_not_recruiting17%
completed857%
unknown321%
recruiting214%

Recent Activity

3 active trials
Showing 5 of 14
recruiting

Vascular Complications After Kidney Transplantation

NCT07531966
recruitingnot_applicable

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

NCT06071429
active_not_recruitingnot_applicable

Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease

NCT04475783
completedphase_3

Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis

NCT01083030
completednot_applicable

Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis

NCT01928498
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07531966

Vascular Complications After Kidney Transplantation

Recruiting
NCT06071429Not Applicable

Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease

Recruiting
NCT04475783Not Applicable

Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease

Active Not Recruiting
NCT01083030Phase 3

Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis

Completed
NCT01928498Not Applicable

Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis

Completed
NCT02228564Not Applicable

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

Completed
NCT04352218Phase 2

Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache

Unknown
NCT00687076Phase 4

Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)

Completed
NCT00798850Not Applicable

Trial of Nonsurgical Treatment of Intermittent Claudication Due to Femoro-popliteal Disease

Completed
NCT03057080Not Applicable

The Role of Percutaneous Angioplasty in Ischemic Leg Ulcer Healing

Completed
NCT02915796Phase 1

Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty

Unknown
NCT01001676Phase 2

Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis

Completed
NCT01083394Phase 4

Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery

Unknown
NCT01174472Phase 2

Drug Eluting Balloon Angioplasty for Dialysis Access Treatment

Completed

All 14 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
14